Archimydes
Archimydes
Upgrading Cardiac Care
Nearly 5% of the US population suffers from a cardiac arrhythmia. Current solutions are entirely inadequate to effectively monitor and triage this population. Archimydes is helping AccurKardia build solutions that change this narrative.
AccurKardia announces FDA approval
Upgrading Cardiac Care
Nearly 5% of the US population suffers from a cardiac arrhythmia. Current solutions are entirely inadequate to effectively monitor and triage this population. Archimydes is helping AccurKardia build solutions that change this narrative.
AccurKardia announces FDA approval
